Ilika（I8A）株式概要イリカはイギリス、アジア、ヨーロッパ、北米で固体電池の設計、製造、開発に従事している。 詳細I8A ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長2/6過去の実績0/6財務の健全性6/6配当金0/6報酬収益は年間71.28%増加すると予測されています リスク分析German市場と比較して、過去 3 か月間の株価の変動が非常に大きい過去5年間で収益は年間5.5%減少しました。 収益が 100 万ドル未満 ( £665K )意味のある時価総額がありません ( €71M )すべてのリスクチェックを見るI8A Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.35300.0% 割高 内在価値ディスカウントEst. Revenue$PastFuture-15m10m2016201920222025202620282031Revenue UK£9.8mEarnings UK£837.5kAdvancedSet Fair ValueView all narrativesIlika plc 競合他社SBFSymbol: DB:CY1KMarket cap: €47.3mHoenleSymbol: XTRA:HNLMarket cap: €57.0mLION E-MobilitySymbol: XTRA:LMIAMarket cap: €23.5mFRIWOSymbol: XTRA:CEAMarket cap: €40.2m価格と性能株価の高値、安値、推移の概要Ilika過去の株価現在の株価UK£0.3552週高値UK£0.5952週安値UK£0.24ベータ2.121ヶ月の変化-2.22%3ヶ月変化28.94%1年変化-3.03%3年間の変化-24.46%5年間の変化-84.00%IPOからの変化-49.86%最新ニュースお知らせ • May 22+ 1 more updateIlika plc Announces Earnings Guidance for Year Ended 30 April 2026Ilika plc announced earnings guidance for year ended 30 April 2026. For the year, The Company expects to announce revenues of approximately £1.1 million, including £100k of commercial revenue from Stereax electrode sales (2025: £1.1 million).お知らせ • Mar 19Ilika plc Announces Positive Feedback on Safety Testing of Goliath Cells by UK Defence AgencyIlika plc announced it has received positive feedback from a UK defence agency on safety tests of its batteries under battlefield conditions, highlighting the potential of the technology for use in high-risk, mission-critical environments where safety is paramount. In December 2025, Ilika delivered prototypes to customers across multiple industries, including an agency which advises the UK Ministry of Defence. The prototypes were subjected to firing range tests, which showed that: A Goliath 10Ah cell could survive a single shot before a thermal event was triggered by a second one; Low state-of-charge 10Ah Goliath cells did not show a thermal event; A Goliath cell showed a delayed reaction before entering thermal runaway; A Goliath cell reached a lower thermal runaway temperature than conventional Nickel Cobalt Aluminium ("NCA") lithium-ion cells; Despite Goliath 10Ah cells storing 3x the energy of conventional NCA cells being tested under equivalent conditions in the same trial, the Goliath cells had a similar thermal response. This independent validation follows the delivery of Goliath prototypes to multiple customers in December 2025 and supports Ilika's ongoing engagement with partners evaluating safety-critical applications. Under certain abuse conditions, conventional lithium-ion batteries can enter a state of thermal runaway, which is a chain reaction in which the battery temperature rises uncontrollably, leading to a fire or explosion.お知らせ • Nov 20Ilika plc to Report First Half, 2026 Results on Jan 22, 2026Ilika plc announced that they will report first half, 2026 results on Jan 22, 2026お知らせ • Aug 28Ilika plc, Annual General Meeting, Sep 23, 2025Ilika plc, Annual General Meeting, Sep 23, 2025. Location: the offices of eversheds sutherland llp, one wood street, london ec2v 7ws United Kingdomお知らせ • Jul 16Ilika plc Announces Award of Government Grant FundingIlika announced it is receiving further grant support to manufacture the first Goliath A-Sample batteries for automotive applications. This support is being provided from the newly launched Demonstrate fund, facilitated by the Advanced Propulsion Centre UK (APC), in a 12-month, £3 million collaboration programme, of which Ilika will receive £1.25 million in grant funding. The programme which will commence on 1 August 2025 will see Ilika partner with HSSMI, a UK based manufacturing consultancy and utilise the electrode production lines at the UK Battery Industrialisation Centre ("UKBIC"). This project, codenamed PRIMED builds upon the developments in the Faraday Battery Challenge, now renamed Battery Innovation Programme, project HISTORY, where Ilika developed a prototype 50Ah SSB, and the APC's Automotive Transformation Fund (ATF) programme SiSTEM, which designed and built an SSB assembly line and undertook production trials of Ilika's electrodes on the giga-scale line at UKBIC. In PRIMED, Ilika will build and test its P2 SSB cells and take them through an industrialisation process to deliver a 50Ah A-Sample. HSSMI will produce a Production Scale Model and Business Case Review to support industrialisation to a gigafactory level.お知らせ • Jun 11Ilika plc to Report Fiscal Year 2025 Results on Jul 17, 2025Ilika plc announced that they will report fiscal year 2025 results on Jul 17, 2025最新情報をもっと見るRecent updatesお知らせ • May 22+ 1 more updateIlika plc Announces Earnings Guidance for Year Ended 30 April 2026Ilika plc announced earnings guidance for year ended 30 April 2026. For the year, The Company expects to announce revenues of approximately £1.1 million, including £100k of commercial revenue from Stereax electrode sales (2025: £1.1 million).お知らせ • Mar 19Ilika plc Announces Positive Feedback on Safety Testing of Goliath Cells by UK Defence AgencyIlika plc announced it has received positive feedback from a UK defence agency on safety tests of its batteries under battlefield conditions, highlighting the potential of the technology for use in high-risk, mission-critical environments where safety is paramount. In December 2025, Ilika delivered prototypes to customers across multiple industries, including an agency which advises the UK Ministry of Defence. The prototypes were subjected to firing range tests, which showed that: A Goliath 10Ah cell could survive a single shot before a thermal event was triggered by a second one; Low state-of-charge 10Ah Goliath cells did not show a thermal event; A Goliath cell showed a delayed reaction before entering thermal runaway; A Goliath cell reached a lower thermal runaway temperature than conventional Nickel Cobalt Aluminium ("NCA") lithium-ion cells; Despite Goliath 10Ah cells storing 3x the energy of conventional NCA cells being tested under equivalent conditions in the same trial, the Goliath cells had a similar thermal response. This independent validation follows the delivery of Goliath prototypes to multiple customers in December 2025 and supports Ilika's ongoing engagement with partners evaluating safety-critical applications. Under certain abuse conditions, conventional lithium-ion batteries can enter a state of thermal runaway, which is a chain reaction in which the battery temperature rises uncontrollably, leading to a fire or explosion.お知らせ • Nov 20Ilika plc to Report First Half, 2026 Results on Jan 22, 2026Ilika plc announced that they will report first half, 2026 results on Jan 22, 2026お知らせ • Aug 28Ilika plc, Annual General Meeting, Sep 23, 2025Ilika plc, Annual General Meeting, Sep 23, 2025. Location: the offices of eversheds sutherland llp, one wood street, london ec2v 7ws United Kingdomお知らせ • Jul 16Ilika plc Announces Award of Government Grant FundingIlika announced it is receiving further grant support to manufacture the first Goliath A-Sample batteries for automotive applications. This support is being provided from the newly launched Demonstrate fund, facilitated by the Advanced Propulsion Centre UK (APC), in a 12-month, £3 million collaboration programme, of which Ilika will receive £1.25 million in grant funding. The programme which will commence on 1 August 2025 will see Ilika partner with HSSMI, a UK based manufacturing consultancy and utilise the electrode production lines at the UK Battery Industrialisation Centre ("UKBIC"). This project, codenamed PRIMED builds upon the developments in the Faraday Battery Challenge, now renamed Battery Innovation Programme, project HISTORY, where Ilika developed a prototype 50Ah SSB, and the APC's Automotive Transformation Fund (ATF) programme SiSTEM, which designed and built an SSB assembly line and undertook production trials of Ilika's electrodes on the giga-scale line at UKBIC. In PRIMED, Ilika will build and test its P2 SSB cells and take them through an industrialisation process to deliver a 50Ah A-Sample. HSSMI will produce a Production Scale Model and Business Case Review to support industrialisation to a gigafactory level.お知らせ • Jun 11Ilika plc to Report Fiscal Year 2025 Results on Jul 17, 2025Ilika plc announced that they will report fiscal year 2025 results on Jul 17, 2025お知らせ • May 29Ilika plc has completed a Follow-on Equity Offering in the amount of £0.9 million.Ilika plc has completed a Follow-on Equity Offering in the amount of £0.9 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,727,273 Price\Range: £0.33 Transaction Features: Regulation Sお知らせ • May 23Ilika plc has filed a Follow-on Equity Offering in the amount of £0.5 million.Ilika plc has filed a Follow-on Equity Offering in the amount of £0.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,515,151 Price\Range: £0.33お知らせ • May 22Ilika plc has filed a Follow-on Equity Offering in the amount of £3 million.Ilika plc has filed a Follow-on Equity Offering in the amount of £3 million. Security Name: Ordinary Share Security Type: Common Stock Securities Offered: 9,009,090 Price\Range: £0.33 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 81,819 Price\Range: £0.33 Transaction Features: Regulation S; Subsequent Direct Listingお知らせ • Apr 15Ilika plc Announces Goliath Battery Achieves Scale-Up MilestoneIlika plc confirmed superior performance of its Goliath batteries manufactured via an industrially scaled process at The UK Battery Industrialisation Centre. This further underpins confidence that the battery is on track on its route to market, reducing costs, increasing range and reducing charging time of electric vehicles. This follows Ilika's 5 February 2025 announcement reporting large-scale preparation of the Goliath electrolyte and successful coating of its proprietary composite electrolyte-electrode. Ilika has used these materials to build a batch of solid state 10Ah prototype cells. After analysis of the performance of these cells, Ilika can verify that the scaled manufacturing process at UKBIC resulted in a higher manufacturing yield and has delivered cells superior in performance to those made with similar starting materials on Ilika's pilot line. This confirms that the tolerances of industrial equipment will unlock further improvements to Goliath SSB technology. The increase in manufacturing yield resulted from enhanced handling robustness after coating and fewer defects from the drying process. The superior performance was measured as higher battery capacity under rapid charging protocols. Ilika announced in October 2023 receipt of grant support from the Automotive Transformation Fund ('ATF') through an 18-month, £2.7 million collaboration programme, codenamed Project SiSTEM, to scale up Ilika's Goliath solid-state battery production capability. Via the programme, Ilika partnered with Mpac Group plc ('Mpac') global supplier of packaging and assembly automation, UKBIC and Agratas, Tata Group's global battery business. Through this collaboration, UKBIC and Ilika have carried out physical trials to demonstrate preparation and roll-to-roll coating of its proprietary solid state materials. The planned trials are now complete and the cell test data announced provide evidence that Ilika's approach to large format solid-state battery manufacture can be carried out with the types of mixing and coating equipment widely used in existing gigafactories. In addition, the trials show that the quality of product made on large scale equipment actually improves with scale. Project SiSTEM has now successfully completed, with the associated delivery of the 1.5MWh solid-state battery assembly line from Mpac planned for second half Current Year 2025. The assembly line will be capable of producing Ilika's Goliath prototype large-format pouch cells to automotive original equipment manufacturers and Tier 1 suppliers, in line with planned delivery timeline.お知らせ • Mar 06Ilika plc Announces Goliath Development ProgressIlika announced it has successfully prototyped a 50Ah Goliath electric vehicle (EV) battery, which is a key targeted outcome of the Faraday Battery Challenge HISTORY programme. The 50Ah prototype is the capacity of battery Ilika will now optimise for its minimum viable product for EVs. The battery is expected to reduce costs, increase the range of EVs and reduce their charging time. This successful prototype build follows the recently announced demonstration of manufacturing in a giga-scale factory setting, using industry standard equipment at the UK Battery Industrialisation Centre, marking the latest step towards commercialisation. It builds on the progress made in 2024 which included the start of commercial testing, shipping of the first batch of prototype Goliath batteries to customers, and the release of validated safety data. Ilika will now undertake further optimisation based on the initial test results, before commencing a build and test programme in H2 CY 2025. The Company is targeting an initial release of batteries of this capacity for partner evaluation from the end of CY 2025.お知らせ • Jan 09Ilika plc Announces the Production of Stereax Batteries for Process Qualification Now CommenceIlika announced that the production of Stereax batteries for process qualification has now commenced. In July 2024, Ilika confirmed that installation of its key equipment had been substantially completed in Cirtec Medical's facility in Lowell, MA, USA. Ilika can now confirm its equipment has been commissioned and successfully passed its User Acceptance Tests (UATs). These production tools include layer deposition machines as well as alignment and patterning machines. This final stage in the commissioning of Stereax new manufacturing facilities means that both Cirtec and Ilika are now satisfied that the equipment meets its requirement for the start of production transfer. To support equipment commissioning, since June 2024, Ilika has delivered a series of batches of cathode-coated wafers to Cirtec, for further processing and verification of subsequent process steps. Process qualification has the aim of refining and tuning the process equipment to achieve specified product performance in preparation for the start of product manufacturing. Ilika currently retains and will operate part of the production equipment in the UK, including that for cathode deposition and cell formation and testing. In August 2023, Ilika and Cirtec Medical announced that they had concluded contractual negotiations by signing a ten-year manufacturing licence to produce the Stereax range of mm-scale batteries at Cirtec's facility in Lowell. This partnership will reinforce Cirtec's ongoing activities in system level miniaturisation for the medical device industry, whilst Ilika will focus on advanced technology development and IP licensing in support of Cirtec's manufacturing and commercialisation activities.Board Change • Dec 30Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent Non-Executive Director Monika Biddulph was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Nov 20Ilika plc Announces Goliath D6 Milestone Reaches Ramping Up Ev Battery CapacityIlika announced that it has successfully reached its D6 milestone by testing 10Ah cells in its Goliath solid state batteries for electric vehicles. The systematic testing to industry standards demonstrates the increased capacity of its cells as it systematically moves along its development roadmap for customers. Building and successfully testing these larger 10Ah cells follows on from the announcement last month on 3 October 2024 of compelling safety data from the testing of its Goliath D5 prototypes. Ilika is now progressing with development towards a D7 design freeze, which it expects to achieve in first quarter 2025. The D7 design freeze will form the basis of a release of 10Ah prototype cells to customers, called the P1.5 prototypes, which will be an upgrade on the 2Ah P1 prototypes released in July 2024. This intermediate P1.5 prototype will address automotive OEM requests for a further proof-point of the technology, as Goliath scales up beyond the capacity of cells released by some competitors. The timing of the P1.5 release will be driven by completion of testing of a batch of batteries based on the D7 design, by second quarter 2025. The 2025 development roadmap will then extend to D8 design freeze, which is also expected in first quarter 2025, and then to the crucial Minimum Viable Product ("MVP") stage, targeted for the end of 2025. Ilika's Goliath MVP, or 50Ah P2 prototypes, will underpin revenue generating licensing opportunities. The modelling of a Goliath-based battery pack for EVs is underway by UK company Balance Batteries, that capitalises on the superior safety, high energy density and fast charging features of the Goliath cells. Early results show that the weight of the battery pack can be reduced materially by up to 100 kg on the basis of Goliath's benefits, compared to a current SUV lithium-ion model of the same energy. This reduction in weight translates into increased driving range on the same level of battery charge and reduced vehicle cost.お知らせ • Nov 15Ilika plc to Report First Half, 2025 Results on Jan 21, 2025Ilika plc announced that they will report first half, 2025 results on Jan 21, 2025お知らせ • Oct 03Ilika plc Completes Testing of Its Goliath D5 PrototypesIlika announces it has completed testing of its Goliath D5 prototypes, thereby further confirming the safety characteristics of Ilika's batteries. The testing reconfirmed the benefits of Goliath relative to lithium-ion equivalent across a number of key variables - reinforcing the fact that Ilika's cells have the potential to provide electric vehicles (EV) with lighter, safer, cheaper batteries with longer ranges and faster charging capabilities. The D5 prototype is designed to build on the characteristics of the D4 data point achieved in 2023. This was achieved by optimising the cell architecture to increase Goliath's unique safety value proposition without compromising cell energy density. The key findings from the testing programme provide further validation along the development curve to D8 and MVP samples during calendar year 2025: Exceptional results from the nail penetration test carried out by University College London as part of the Faraday Institution funded Safebatt Industrial Sprint programme. The results classify puncturing the D5 prototypes as a EUCAR 3 hazard event, with no leakage, no venting, no fire or flame, no rupture and no explosion. In contrast, puncturing the benchmark lithium-ion battery resulted in a higher EUCAR 6 event, i.e. a rupture accompanied by flying parts of the active mass, fire and flame. Components confirmed to be non-flammable by DEKRA, the world's largest independent, non-listed expert organisation in testing, certification and inspection. Temperatures during failure approximately 300°C lower than comparable Li-ion cells shown in Accelerated Rate Calorimetry testing carried out as part the Industrial Sprint, by the University of Oxford. Improved capacity at higher discharge rates. o D5 prototypes can be discharged at twice the rate of P1 prototypes without impacting their capacity. Improved safety performance of Goliath batteries relative to conventional lithium ion means that EV designers can reduce the mechanical protection and reinforcement that would otherwise be required to protect the battery pack. In turn, this enables lighter and less expensive EV designs that have a longer range for the same amount of energy. The D5 data point makes this improved safety performance clear.お知らせ • Sep 05Ilika plc Announces Goliath Safety Test ResultsIlika plc announced that safety tests undertaken by independent expert assessors have demonstrated the superior safety of Goliath solid state cell battery prototypes relative to lithium-ion equivalent batteries. University College London carried out the nail penetration test, a standard battery safety assessment, on Ilika's Goliath P1 prototype cells. This destructive test creates an internal electrical short-circuit inside a cell by piercing the cell with a metal nail. The test simulates a catastrophic incident that would typically cause energy-dense lithium-ion cells with lithium nickel manganese cobalt oxide ("NMC") cathode chemistry (, to dangerously swell, rupture, explode, and catch fire in a process known as thermal runaway, often leading to temperatures above 600°C. Goliath P1 cells also use high-energy NMC cathode chemistry, however in the nail penetration tests the P1 cells neither exploded nor caught fire, with external temperatures remaining below 80°C. With electric vehicles ("EVs") expected to play a key role in the NetZero transition, solid state batteries are anticipated to provide a safer battery solution for next-generation EVs. It is expected that a combination of improved safety performance and high energy density will reduce the complexity of battery packs. The reduction of parasitic packaging is, in turn, expected to lead to lighter and safer vehicles with longer driving range. Testing was carried out as part of a short collaborative study, in association with the Faraday Institution SafeBatt project,which aims to develop an improved understanding of safety in next generation battery technologies. The study involves Ilika alongside researchers from the University of Oxford and University College London. The core Safebatt project explores the science of battery safety and works closely with UK battery developers and manufacturers like Ilika to inform industrial design and deployment.お知らせ • Aug 29Ilika plc, Annual General Meeting, Sep 24, 2024Ilika plc, Annual General Meeting, Sep 24, 2024. Location: the offices of eversheds sutherlands llp, one wood street, ec2v 7ws, london United KingdomNew Risk • Jul 17New major risk - Revenue and earnings growthEarnings have declined by 21% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 21% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (5.3% increase in shares outstanding). Revenue is less than US$5m (UK£2.1m revenue, or US$2.7m). Market cap is less than US$100m (€54.5m market cap, or US$59.5m).Reported Earnings • Jul 12Full year 2024 earnings released: UK£0.03 loss per share (vs UK£0.046 loss in FY 2023)Full year 2024 results: UK£0.03 loss per share (improved from UK£0.046 loss in FY 2023). Net loss: UK£4.81m (loss narrowed 34% from FY 2023). Revenue is forecast to grow 54% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Electrical industry in Germany. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has fallen by 46% per year, which means it is performing significantly worse than earnings.New Risk • Jun 03New major risk - Revenue and earnings growthEarnings have declined by 26% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 26% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (4.2% increase in shares outstanding). Revenue is less than US$5m (UK£1.8m revenue, or US$2.3m). Market cap is less than US$100m (€53.3m market cap, or US$57.7m).New Risk • May 19New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 4.2% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (22% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (UK£5.0m net loss in 2 years). Shareholders have been diluted in the past year (4.2% increase in shares outstanding). Revenue is less than US$5m (UK£1.8m revenue, or US$2.3m). Market cap is less than US$100m (€54.0m market cap, or US$58.8m).お知らせ • May 17Ilika plc to Report Fiscal Year 2024 Results on Jul 11, 2024Ilika plc announced that they will report fiscal year 2024 results on Jul 11, 2024New Risk • Apr 26New major risk - Revenue and earnings growthEarnings have declined by 26% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (20% average weekly change). Earnings have declined by 26% per year over the past 5 years. Minor Risks Revenue is less than US$5m (UK£1.8m revenue, or US$2.3m). Market cap is less than US$100m (€56.6m market cap, or US$60.6m).New Risk • Apr 24New major risk - Revenue and earnings growthEarnings have declined by 26% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 26% per year over the past 5 years. Minor Risks Revenue is less than US$5m (UK£1.8m revenue, or US$2.3m). Market cap is less than US$100m (€52.8m market cap, or US$56.5m).お知らせ • Apr 23Ilika plc Provides Revenue Guidance for the Year Ended 30 April 2024Ilika plc announced that unaudited trading for the year ended 30 April 2024 has been in line with current market expectations and the Company expects to generate revenue of approximately £2.0 million (FY 2023: £0.8 million).Reported Earnings • Jan 23First half 2024 earnings released: UK£0.016 loss per share (vs UK£0.026 loss in 1H 2023)First half 2024 results: UK£0.016 loss per share (improved from UK£0.026 loss in 1H 2023). Net loss: UK£2.59m (loss narrowed 37% from 1H 2023). Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 8.5% growth forecast for the Electrical industry in Germany. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has fallen by 47% per year, which means it is performing significantly worse than earnings.お知らせ • Nov 24Ilika plc to Report First Half, 2024 Results on Jan 23, 2024Ilika plc announced that they will report first half, 2024 results on Jan 23, 2024Reported Earnings • Aug 20Full year 2023 earnings released: UK£0.046 loss per share (vs UK£0.047 loss in FY 2022)Full year 2023 results: UK£0.046 loss per share. Net loss: UK£7.30m (loss widened 2.3% from FY 2022). Revenue is forecast to grow 49% p.a. on average during the next 3 years, compared to a 8.7% growth forecast for the Electrical industry in Germany.お知らせ • Aug 18Ilika plc, Annual General Meeting, Sep 20, 2023Ilika plc, Annual General Meeting, Sep 20, 2023, at 13:00 Coordinated Universal Time. Location: At the offices of Eversheds Sutherlands LLP One Wood Street, London EC2V 7WS London United KingdomReported Earnings • Jul 14Full year 2023 earnings released: UK£0.046 loss per share (vs UK£0.047 loss in FY 2022)Full year 2023 results: UK£0.046 loss per share. Net loss: UK£7.30m (loss widened 2.3% from FY 2022). Revenue is forecast to grow 46% p.a. on average during the next 3 years, compared to a 8.4% growth forecast for the Electrical industry in Germany.お知らせ • May 23Ilika plc to Report Fiscal Year 2023 Results on Jul 13, 2023Ilika plc announced that they will report fiscal year 2023 results on Jul 13, 2023お知らせ • May 22Ilika plc Provides Revenue Guidance for the Year Ended 30 April 2023Ilika plc announced that unaudited trading for the year ended 30 April 2023 has been in line with management expectations. The Company expects to announce revenues of approximately £0.8 million (2022: £0.5 million).お知らせ • May 11Ilika plc Announces First Customer Shipments of Stereax M300 Stacked BatteriesIlika announced it has made a number of first customer shipments of stacked Stereax® M300 batteries from its UK manufacturing facility. Further to its announcement of 11 April 2023, these shipments are the first of a series of planned deliveries of Stereax M300 batteries to customers including CubeWorks, the developer of millimeter-scale smart sensing solutions for IoT, and Lura Health, a leading developer of wearable intraoral biosensors for salivary diagnostics. Stereax batteries can be configured such that they can be stacked, which provides customers with the flexibility to adapt the battery capacity for their application. The small form factor of M300 batteries is of particular interest to Ilika's customers due to their compact, high-density and high-power characteristics. CubeWorks is designing CubiSensTM, a next generation sensing platform, aiming to transform biopharma cold chain logistics, security control, asset protection and environment monitoring. Lura Health has developed the world's first salivary diagnostic, wearable sensor, first embedded in traditional orthodontic appliances including retainers, bands, and brackets, and eventually in prosthodontic appliances including dentures, implants, and bridges. Worn in the mouth continually throughout the day, it continually measures analytes in saliva, and provides real time streams of health data by Bluetooth Low Energy to a smartphone. Cirtec Update Ilika and Cirtec Medical LLC ('Cirtec'), a strategic outsourcing partner of complex medical devices including minimally invasive and active implantable devices, are continuing to finalise the terms of their intended partnership.Board Change • Mar 24Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. Independent Non-Executive Director Monika Biddulph was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Reported Earnings • Jan 20First half 2023 earnings released: UK£0.03 loss per share (vs UK£0.022 loss in 1H 2022)First half 2023 results: UK£0.03 loss per share (further deteriorated from UK£0.022 loss in 1H 2022). Net loss: UK£4.08m (loss widened 25% from 1H 2022). Revenue is forecast to grow 63% p.a. on average during the next 3 years, compared to a 8.9% growth forecast for the Electrical industry in Germany.お知らせ • Nov 17+ 1 more updateIlika plc Appoints Jason Stewart as Chief Financial Officer to the Board of Directors, Effective January 3, 2023Ilika plc announced the appointment of Jason Stewart as Chief Financial Officer (CFO) to the Board of Directors, effective as of 3 January 2023. Jason is a senior Finance Director and Executive with significant commercial experience in the manufacturing sector. Most recently, Jason was the Interim CFO at Sunseeker International ltd where he successfully managed the company through the COVID-19 crisis, managing costs and re-establishing production subsequent to the lockdown. A CIMA qualified accountant, Jason joined Sunseeker in 2010 and held several senior roles including Director of Commercial Finance & IT andHead of Strategy & Performance Management. Prior to this, he spent five years with B&Q ltd in various finance roles after he completed his professional training with Kerry Foods ltd. He brings with him a wealth of knowledge across financial functions, with particular expertise in project appraisals, performance management and business development. The appointment follows the departure of the previous CFO, Steve Boydell, who stepped down in July this year to pursue other opportunities. Jason Robert Fredrick Stewart, age 44, he was Director of Sunseeker USA Holdings Inc.Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. Independent Non-Executive Director Monika Biddulph was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Reported Earnings • Aug 20Full year 2022 earnings released: UK£0.047 loss per share (vs UK£0.025 loss in FY 2021)Full year 2022 results: UK£0.047 loss per share (down from UK£0.025 loss in FY 2021). Net loss: UK£7.13m (loss widened 102% from FY 2021). Over the next year, revenue is forecast to grow 102%, compared to a 17% growth forecast for the Electrical industry in Germany.お知らせ • Aug 18Ilika plc, Annual General Meeting, Sep 20, 2022Ilika plc, Annual General Meeting, Sep 20, 2022, at 13:00 Coordinated Universal Time. Location: Eversheds Sutherlands LLP One Wood Street London United KingdomReported Earnings • Jul 14Full year 2022 earnings released: UK£0.047 loss per share (vs UK£0.025 loss in FY 2021)Full year 2022 results: UK£0.047 loss per share (down from UK£0.025 loss in FY 2021). Net loss: UK£7.13m (loss widened 102% from FY 2021). Over the next year, revenue is forecast to grow 81%, compared to a 11% growth forecast for the industry in Germany.お知らせ • May 12+ 1 more updateIlika plc to Report Fiscal Year 2022 Results on Jul 13, 2022Ilika plc announced that they will report fiscal year 2022 results on Jul 13, 2022Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 1 highly experienced director. Independent Non-Executive Director Monika Biddulph was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Recent Insider Transactions • Mar 23Finance Director recently sold €143k worth of stockOn the 21st of March, Stephen Boydell sold around 112k shares on-market at roughly €1.28 per share. This was the largest sale by an insider in the last 3 months. Stephen has been a seller over the last 12 months, reducing personal holdings by €146k.お知らせ • Feb 26Ilika plc Announces Resignation of Steve Boydell, Chief Financial Officer, with Effect from July 2022Ilika plc announced the resignation of Steve Boydell, Chief Financial Officer, with effect from July 2022. Steve has decided to step down from his position to pursue other opportunities. To ensure an orderly transition, Steve will continue in his role until after the completion of the Company's current financial reporting period. The Company has commenced the search for a successor and a further announcement will be made in due course.Board Change • Feb 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Independent Non-Executive Director Monika Biddulph was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Reported Earnings • Jan 22First half 2022 earnings: EPS in line with analyst expectations despite revenue beatFirst half 2022 results: UK£0.022 loss per share (down from UK£0.012 loss in 1H 2021). Net loss: UK£3.27m (loss widened 101% from 1H 2021). Revenue exceeded analyst estimates by 61%. Over the next year, revenue is forecast to grow 193%, compared to a 14% growth forecast for the industry in Germany.Reported Earnings • Aug 20Full year 2021 earnings released: UK£0.025 loss per share (vs UK£0.03 loss in FY 2020)Full year 2021 results: Net loss: UK£3.53m (loss widened 14% from FY 2020).Reported Earnings • Jul 08Full year 2021 earnings released: UK£0.025 loss per share (vs UK£0.03 loss in FY 2020)Full year 2021 results: Net loss: UK£3.53m (loss widened 14% from FY 2020).お知らせ • Jun 22Ilika plc Provides Revenues Guidance for the Year Ended April 30, 2021Ilika plc provided revenues guidance for the year ended April 30, 2021. Trading for the year ended 30 April 2021 has been in line with management expectations. The company expects to announce revenues of approximately £2.3 million (2020: £2.8 million).Is New 90 Day High Low • Jan 26New 90-day high: €3.20The company is up 233% from its price of €0.96 on 28 October 2020. The German market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electrical industry, which is up 54% over the same period.Reported Earnings • Jan 16First half 2021 earnings released: UK£0.012 loss per shareFirst half 2021 results: Net loss: UK£1.62m (loss widened 13% from 1H 2020).Is New 90 Day High Low • Dec 23New 90-day high: €1.25The company is up 40% from its price of €0.89 on 24 September 2020. The German market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electrical industry, which is up 18% over the same period.Is New 90 Day High Low • Nov 12New 90-day high: €1.12The company is up 65% from its price of €0.68 on 14 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electrical industry, which is up 12% over the same period.お知らせ • Nov 12Ilika plc to Report First Half, 2021 Results on Jan 14, 2021Ilika plc announced that they will report first half, 2021 results on Jan 14, 2021株主還元I8ADE ElectricalDE 市場7D1.1%4.9%3.9%1Y-3.0%106.6%2.6%株主還元を見る業界別リターン: I8A過去 1 年間で106.6 % の収益を上げたGerman Electrical業界を下回りました。リターン対市場: I8Aは、過去 1 年間で2.6 % のリターンを上げたGerman市場を下回りました。価格変動Is I8A's price volatile compared to industry and market?I8A volatilityI8A Average Weekly Movement28.1%Electrical Industry Average Movement7.5%Market Average Movement6.1%10% most volatile stocks in DE Market12.9%10% least volatile stocks in DE Market2.7%安定した株価: I8Aの株価は、 German市場と比較して過去 3 か月間で変動しています。時間の経過による変動: I8Aの 週次ボラティリティ は、過去 1 年間で21%から28%に増加しました。会社概要設立従業員CEO（最高経営責任者ウェブサイト200470Graeme Purdywww.ilika.comイリカはイギリス、アジア、ヨーロッパ、北米で固体電池の設計、生産、開発に従事している。同社は電気自動車やコードレス家電向けにGoliathの名称で輸送用固体電池を提供している。また、Stereaxの名称で、神経刺激、心臓センシング、スマート整形外科、スマート歯科矯正、スマートコンタクトレンズ、産業用IoTセンサー向けにヘルスケア用固体電池を提供している。イリカは2004年に設立され、英国ロムジーに本社を置いている。もっと見るIlika plc 基礎のまとめIlika の収益と売上を時価総額と比較するとどうか。I8A 基礎統計学時価総額€71.41m収益（TTM）-€8.52m売上高(TTM)€771.05k92.6xP/Sレシオ-8.4xPER（株価収益率I8A は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計I8A 損益計算書（TTM）収益UK£664.50k売上原価UK£525.50k売上総利益UK£139.00kその他の費用UK£7.48m収益-UK£7.34m直近の収益報告Oct 31, 2025次回決算日Jul 29, 2026一株当たり利益（EPS）-0.041グロス・マージン20.92%純利益率-1,104.47%有利子負債／自己資本比率0%I8A の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/25 08:06終値2026/05/25 00:00収益2025/10/31年間収益2025/04/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Ilika plc 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。5 アナリスト機関Ian McInallyCavendishChristopher DonnellanCavendishJohn-Marc BunceCavendish2 その他のアナリストを表示
お知らせ • May 22+ 1 more updateIlika plc Announces Earnings Guidance for Year Ended 30 April 2026Ilika plc announced earnings guidance for year ended 30 April 2026. For the year, The Company expects to announce revenues of approximately £1.1 million, including £100k of commercial revenue from Stereax electrode sales (2025: £1.1 million).
お知らせ • Mar 19Ilika plc Announces Positive Feedback on Safety Testing of Goliath Cells by UK Defence AgencyIlika plc announced it has received positive feedback from a UK defence agency on safety tests of its batteries under battlefield conditions, highlighting the potential of the technology for use in high-risk, mission-critical environments where safety is paramount. In December 2025, Ilika delivered prototypes to customers across multiple industries, including an agency which advises the UK Ministry of Defence. The prototypes were subjected to firing range tests, which showed that: A Goliath 10Ah cell could survive a single shot before a thermal event was triggered by a second one; Low state-of-charge 10Ah Goliath cells did not show a thermal event; A Goliath cell showed a delayed reaction before entering thermal runaway; A Goliath cell reached a lower thermal runaway temperature than conventional Nickel Cobalt Aluminium ("NCA") lithium-ion cells; Despite Goliath 10Ah cells storing 3x the energy of conventional NCA cells being tested under equivalent conditions in the same trial, the Goliath cells had a similar thermal response. This independent validation follows the delivery of Goliath prototypes to multiple customers in December 2025 and supports Ilika's ongoing engagement with partners evaluating safety-critical applications. Under certain abuse conditions, conventional lithium-ion batteries can enter a state of thermal runaway, which is a chain reaction in which the battery temperature rises uncontrollably, leading to a fire or explosion.
お知らせ • Nov 20Ilika plc to Report First Half, 2026 Results on Jan 22, 2026Ilika plc announced that they will report first half, 2026 results on Jan 22, 2026
お知らせ • Aug 28Ilika plc, Annual General Meeting, Sep 23, 2025Ilika plc, Annual General Meeting, Sep 23, 2025. Location: the offices of eversheds sutherland llp, one wood street, london ec2v 7ws United Kingdom
お知らせ • Jul 16Ilika plc Announces Award of Government Grant FundingIlika announced it is receiving further grant support to manufacture the first Goliath A-Sample batteries for automotive applications. This support is being provided from the newly launched Demonstrate fund, facilitated by the Advanced Propulsion Centre UK (APC), in a 12-month, £3 million collaboration programme, of which Ilika will receive £1.25 million in grant funding. The programme which will commence on 1 August 2025 will see Ilika partner with HSSMI, a UK based manufacturing consultancy and utilise the electrode production lines at the UK Battery Industrialisation Centre ("UKBIC"). This project, codenamed PRIMED builds upon the developments in the Faraday Battery Challenge, now renamed Battery Innovation Programme, project HISTORY, where Ilika developed a prototype 50Ah SSB, and the APC's Automotive Transformation Fund (ATF) programme SiSTEM, which designed and built an SSB assembly line and undertook production trials of Ilika's electrodes on the giga-scale line at UKBIC. In PRIMED, Ilika will build and test its P2 SSB cells and take them through an industrialisation process to deliver a 50Ah A-Sample. HSSMI will produce a Production Scale Model and Business Case Review to support industrialisation to a gigafactory level.
お知らせ • Jun 11Ilika plc to Report Fiscal Year 2025 Results on Jul 17, 2025Ilika plc announced that they will report fiscal year 2025 results on Jul 17, 2025
お知らせ • May 22+ 1 more updateIlika plc Announces Earnings Guidance for Year Ended 30 April 2026Ilika plc announced earnings guidance for year ended 30 April 2026. For the year, The Company expects to announce revenues of approximately £1.1 million, including £100k of commercial revenue from Stereax electrode sales (2025: £1.1 million).
お知らせ • Mar 19Ilika plc Announces Positive Feedback on Safety Testing of Goliath Cells by UK Defence AgencyIlika plc announced it has received positive feedback from a UK defence agency on safety tests of its batteries under battlefield conditions, highlighting the potential of the technology for use in high-risk, mission-critical environments where safety is paramount. In December 2025, Ilika delivered prototypes to customers across multiple industries, including an agency which advises the UK Ministry of Defence. The prototypes were subjected to firing range tests, which showed that: A Goliath 10Ah cell could survive a single shot before a thermal event was triggered by a second one; Low state-of-charge 10Ah Goliath cells did not show a thermal event; A Goliath cell showed a delayed reaction before entering thermal runaway; A Goliath cell reached a lower thermal runaway temperature than conventional Nickel Cobalt Aluminium ("NCA") lithium-ion cells; Despite Goliath 10Ah cells storing 3x the energy of conventional NCA cells being tested under equivalent conditions in the same trial, the Goliath cells had a similar thermal response. This independent validation follows the delivery of Goliath prototypes to multiple customers in December 2025 and supports Ilika's ongoing engagement with partners evaluating safety-critical applications. Under certain abuse conditions, conventional lithium-ion batteries can enter a state of thermal runaway, which is a chain reaction in which the battery temperature rises uncontrollably, leading to a fire or explosion.
お知らせ • Nov 20Ilika plc to Report First Half, 2026 Results on Jan 22, 2026Ilika plc announced that they will report first half, 2026 results on Jan 22, 2026
お知らせ • Aug 28Ilika plc, Annual General Meeting, Sep 23, 2025Ilika plc, Annual General Meeting, Sep 23, 2025. Location: the offices of eversheds sutherland llp, one wood street, london ec2v 7ws United Kingdom
お知らせ • Jul 16Ilika plc Announces Award of Government Grant FundingIlika announced it is receiving further grant support to manufacture the first Goliath A-Sample batteries for automotive applications. This support is being provided from the newly launched Demonstrate fund, facilitated by the Advanced Propulsion Centre UK (APC), in a 12-month, £3 million collaboration programme, of which Ilika will receive £1.25 million in grant funding. The programme which will commence on 1 August 2025 will see Ilika partner with HSSMI, a UK based manufacturing consultancy and utilise the electrode production lines at the UK Battery Industrialisation Centre ("UKBIC"). This project, codenamed PRIMED builds upon the developments in the Faraday Battery Challenge, now renamed Battery Innovation Programme, project HISTORY, where Ilika developed a prototype 50Ah SSB, and the APC's Automotive Transformation Fund (ATF) programme SiSTEM, which designed and built an SSB assembly line and undertook production trials of Ilika's electrodes on the giga-scale line at UKBIC. In PRIMED, Ilika will build and test its P2 SSB cells and take them through an industrialisation process to deliver a 50Ah A-Sample. HSSMI will produce a Production Scale Model and Business Case Review to support industrialisation to a gigafactory level.
お知らせ • Jun 11Ilika plc to Report Fiscal Year 2025 Results on Jul 17, 2025Ilika plc announced that they will report fiscal year 2025 results on Jul 17, 2025
お知らせ • May 29Ilika plc has completed a Follow-on Equity Offering in the amount of £0.9 million.Ilika plc has completed a Follow-on Equity Offering in the amount of £0.9 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,727,273 Price\Range: £0.33 Transaction Features: Regulation S
お知らせ • May 23Ilika plc has filed a Follow-on Equity Offering in the amount of £0.5 million.Ilika plc has filed a Follow-on Equity Offering in the amount of £0.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,515,151 Price\Range: £0.33
お知らせ • May 22Ilika plc has filed a Follow-on Equity Offering in the amount of £3 million.Ilika plc has filed a Follow-on Equity Offering in the amount of £3 million. Security Name: Ordinary Share Security Type: Common Stock Securities Offered: 9,009,090 Price\Range: £0.33 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 81,819 Price\Range: £0.33 Transaction Features: Regulation S; Subsequent Direct Listing
お知らせ • Apr 15Ilika plc Announces Goliath Battery Achieves Scale-Up MilestoneIlika plc confirmed superior performance of its Goliath batteries manufactured via an industrially scaled process at The UK Battery Industrialisation Centre. This further underpins confidence that the battery is on track on its route to market, reducing costs, increasing range and reducing charging time of electric vehicles. This follows Ilika's 5 February 2025 announcement reporting large-scale preparation of the Goliath electrolyte and successful coating of its proprietary composite electrolyte-electrode. Ilika has used these materials to build a batch of solid state 10Ah prototype cells. After analysis of the performance of these cells, Ilika can verify that the scaled manufacturing process at UKBIC resulted in a higher manufacturing yield and has delivered cells superior in performance to those made with similar starting materials on Ilika's pilot line. This confirms that the tolerances of industrial equipment will unlock further improvements to Goliath SSB technology. The increase in manufacturing yield resulted from enhanced handling robustness after coating and fewer defects from the drying process. The superior performance was measured as higher battery capacity under rapid charging protocols. Ilika announced in October 2023 receipt of grant support from the Automotive Transformation Fund ('ATF') through an 18-month, £2.7 million collaboration programme, codenamed Project SiSTEM, to scale up Ilika's Goliath solid-state battery production capability. Via the programme, Ilika partnered with Mpac Group plc ('Mpac') global supplier of packaging and assembly automation, UKBIC and Agratas, Tata Group's global battery business. Through this collaboration, UKBIC and Ilika have carried out physical trials to demonstrate preparation and roll-to-roll coating of its proprietary solid state materials. The planned trials are now complete and the cell test data announced provide evidence that Ilika's approach to large format solid-state battery manufacture can be carried out with the types of mixing and coating equipment widely used in existing gigafactories. In addition, the trials show that the quality of product made on large scale equipment actually improves with scale. Project SiSTEM has now successfully completed, with the associated delivery of the 1.5MWh solid-state battery assembly line from Mpac planned for second half Current Year 2025. The assembly line will be capable of producing Ilika's Goliath prototype large-format pouch cells to automotive original equipment manufacturers and Tier 1 suppliers, in line with planned delivery timeline.
お知らせ • Mar 06Ilika plc Announces Goliath Development ProgressIlika announced it has successfully prototyped a 50Ah Goliath electric vehicle (EV) battery, which is a key targeted outcome of the Faraday Battery Challenge HISTORY programme. The 50Ah prototype is the capacity of battery Ilika will now optimise for its minimum viable product for EVs. The battery is expected to reduce costs, increase the range of EVs and reduce their charging time. This successful prototype build follows the recently announced demonstration of manufacturing in a giga-scale factory setting, using industry standard equipment at the UK Battery Industrialisation Centre, marking the latest step towards commercialisation. It builds on the progress made in 2024 which included the start of commercial testing, shipping of the first batch of prototype Goliath batteries to customers, and the release of validated safety data. Ilika will now undertake further optimisation based on the initial test results, before commencing a build and test programme in H2 CY 2025. The Company is targeting an initial release of batteries of this capacity for partner evaluation from the end of CY 2025.
お知らせ • Jan 09Ilika plc Announces the Production of Stereax Batteries for Process Qualification Now CommenceIlika announced that the production of Stereax batteries for process qualification has now commenced. In July 2024, Ilika confirmed that installation of its key equipment had been substantially completed in Cirtec Medical's facility in Lowell, MA, USA. Ilika can now confirm its equipment has been commissioned and successfully passed its User Acceptance Tests (UATs). These production tools include layer deposition machines as well as alignment and patterning machines. This final stage in the commissioning of Stereax new manufacturing facilities means that both Cirtec and Ilika are now satisfied that the equipment meets its requirement for the start of production transfer. To support equipment commissioning, since June 2024, Ilika has delivered a series of batches of cathode-coated wafers to Cirtec, for further processing and verification of subsequent process steps. Process qualification has the aim of refining and tuning the process equipment to achieve specified product performance in preparation for the start of product manufacturing. Ilika currently retains and will operate part of the production equipment in the UK, including that for cathode deposition and cell formation and testing. In August 2023, Ilika and Cirtec Medical announced that they had concluded contractual negotiations by signing a ten-year manufacturing licence to produce the Stereax range of mm-scale batteries at Cirtec's facility in Lowell. This partnership will reinforce Cirtec's ongoing activities in system level miniaturisation for the medical device industry, whilst Ilika will focus on advanced technology development and IP licensing in support of Cirtec's manufacturing and commercialisation activities.
Board Change • Dec 30Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent Non-Executive Director Monika Biddulph was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Nov 20Ilika plc Announces Goliath D6 Milestone Reaches Ramping Up Ev Battery CapacityIlika announced that it has successfully reached its D6 milestone by testing 10Ah cells in its Goliath solid state batteries for electric vehicles. The systematic testing to industry standards demonstrates the increased capacity of its cells as it systematically moves along its development roadmap for customers. Building and successfully testing these larger 10Ah cells follows on from the announcement last month on 3 October 2024 of compelling safety data from the testing of its Goliath D5 prototypes. Ilika is now progressing with development towards a D7 design freeze, which it expects to achieve in first quarter 2025. The D7 design freeze will form the basis of a release of 10Ah prototype cells to customers, called the P1.5 prototypes, which will be an upgrade on the 2Ah P1 prototypes released in July 2024. This intermediate P1.5 prototype will address automotive OEM requests for a further proof-point of the technology, as Goliath scales up beyond the capacity of cells released by some competitors. The timing of the P1.5 release will be driven by completion of testing of a batch of batteries based on the D7 design, by second quarter 2025. The 2025 development roadmap will then extend to D8 design freeze, which is also expected in first quarter 2025, and then to the crucial Minimum Viable Product ("MVP") stage, targeted for the end of 2025. Ilika's Goliath MVP, or 50Ah P2 prototypes, will underpin revenue generating licensing opportunities. The modelling of a Goliath-based battery pack for EVs is underway by UK company Balance Batteries, that capitalises on the superior safety, high energy density and fast charging features of the Goliath cells. Early results show that the weight of the battery pack can be reduced materially by up to 100 kg on the basis of Goliath's benefits, compared to a current SUV lithium-ion model of the same energy. This reduction in weight translates into increased driving range on the same level of battery charge and reduced vehicle cost.
お知らせ • Nov 15Ilika plc to Report First Half, 2025 Results on Jan 21, 2025Ilika plc announced that they will report first half, 2025 results on Jan 21, 2025
お知らせ • Oct 03Ilika plc Completes Testing of Its Goliath D5 PrototypesIlika announces it has completed testing of its Goliath D5 prototypes, thereby further confirming the safety characteristics of Ilika's batteries. The testing reconfirmed the benefits of Goliath relative to lithium-ion equivalent across a number of key variables - reinforcing the fact that Ilika's cells have the potential to provide electric vehicles (EV) with lighter, safer, cheaper batteries with longer ranges and faster charging capabilities. The D5 prototype is designed to build on the characteristics of the D4 data point achieved in 2023. This was achieved by optimising the cell architecture to increase Goliath's unique safety value proposition without compromising cell energy density. The key findings from the testing programme provide further validation along the development curve to D8 and MVP samples during calendar year 2025: Exceptional results from the nail penetration test carried out by University College London as part of the Faraday Institution funded Safebatt Industrial Sprint programme. The results classify puncturing the D5 prototypes as a EUCAR 3 hazard event, with no leakage, no venting, no fire or flame, no rupture and no explosion. In contrast, puncturing the benchmark lithium-ion battery resulted in a higher EUCAR 6 event, i.e. a rupture accompanied by flying parts of the active mass, fire and flame. Components confirmed to be non-flammable by DEKRA, the world's largest independent, non-listed expert organisation in testing, certification and inspection. Temperatures during failure approximately 300°C lower than comparable Li-ion cells shown in Accelerated Rate Calorimetry testing carried out as part the Industrial Sprint, by the University of Oxford. Improved capacity at higher discharge rates. o D5 prototypes can be discharged at twice the rate of P1 prototypes without impacting their capacity. Improved safety performance of Goliath batteries relative to conventional lithium ion means that EV designers can reduce the mechanical protection and reinforcement that would otherwise be required to protect the battery pack. In turn, this enables lighter and less expensive EV designs that have a longer range for the same amount of energy. The D5 data point makes this improved safety performance clear.
お知らせ • Sep 05Ilika plc Announces Goliath Safety Test ResultsIlika plc announced that safety tests undertaken by independent expert assessors have demonstrated the superior safety of Goliath solid state cell battery prototypes relative to lithium-ion equivalent batteries. University College London carried out the nail penetration test, a standard battery safety assessment, on Ilika's Goliath P1 prototype cells. This destructive test creates an internal electrical short-circuit inside a cell by piercing the cell with a metal nail. The test simulates a catastrophic incident that would typically cause energy-dense lithium-ion cells with lithium nickel manganese cobalt oxide ("NMC") cathode chemistry (, to dangerously swell, rupture, explode, and catch fire in a process known as thermal runaway, often leading to temperatures above 600°C. Goliath P1 cells also use high-energy NMC cathode chemistry, however in the nail penetration tests the P1 cells neither exploded nor caught fire, with external temperatures remaining below 80°C. With electric vehicles ("EVs") expected to play a key role in the NetZero transition, solid state batteries are anticipated to provide a safer battery solution for next-generation EVs. It is expected that a combination of improved safety performance and high energy density will reduce the complexity of battery packs. The reduction of parasitic packaging is, in turn, expected to lead to lighter and safer vehicles with longer driving range. Testing was carried out as part of a short collaborative study, in association with the Faraday Institution SafeBatt project,which aims to develop an improved understanding of safety in next generation battery technologies. The study involves Ilika alongside researchers from the University of Oxford and University College London. The core Safebatt project explores the science of battery safety and works closely with UK battery developers and manufacturers like Ilika to inform industrial design and deployment.
お知らせ • Aug 29Ilika plc, Annual General Meeting, Sep 24, 2024Ilika plc, Annual General Meeting, Sep 24, 2024. Location: the offices of eversheds sutherlands llp, one wood street, ec2v 7ws, london United Kingdom
New Risk • Jul 17New major risk - Revenue and earnings growthEarnings have declined by 21% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 21% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (5.3% increase in shares outstanding). Revenue is less than US$5m (UK£2.1m revenue, or US$2.7m). Market cap is less than US$100m (€54.5m market cap, or US$59.5m).
Reported Earnings • Jul 12Full year 2024 earnings released: UK£0.03 loss per share (vs UK£0.046 loss in FY 2023)Full year 2024 results: UK£0.03 loss per share (improved from UK£0.046 loss in FY 2023). Net loss: UK£4.81m (loss narrowed 34% from FY 2023). Revenue is forecast to grow 54% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Electrical industry in Germany. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has fallen by 46% per year, which means it is performing significantly worse than earnings.
New Risk • Jun 03New major risk - Revenue and earnings growthEarnings have declined by 26% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 26% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (4.2% increase in shares outstanding). Revenue is less than US$5m (UK£1.8m revenue, or US$2.3m). Market cap is less than US$100m (€53.3m market cap, or US$57.7m).
New Risk • May 19New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 4.2% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (22% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (UK£5.0m net loss in 2 years). Shareholders have been diluted in the past year (4.2% increase in shares outstanding). Revenue is less than US$5m (UK£1.8m revenue, or US$2.3m). Market cap is less than US$100m (€54.0m market cap, or US$58.8m).
お知らせ • May 17Ilika plc to Report Fiscal Year 2024 Results on Jul 11, 2024Ilika plc announced that they will report fiscal year 2024 results on Jul 11, 2024
New Risk • Apr 26New major risk - Revenue and earnings growthEarnings have declined by 26% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (20% average weekly change). Earnings have declined by 26% per year over the past 5 years. Minor Risks Revenue is less than US$5m (UK£1.8m revenue, or US$2.3m). Market cap is less than US$100m (€56.6m market cap, or US$60.6m).
New Risk • Apr 24New major risk - Revenue and earnings growthEarnings have declined by 26% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 26% per year over the past 5 years. Minor Risks Revenue is less than US$5m (UK£1.8m revenue, or US$2.3m). Market cap is less than US$100m (€52.8m market cap, or US$56.5m).
お知らせ • Apr 23Ilika plc Provides Revenue Guidance for the Year Ended 30 April 2024Ilika plc announced that unaudited trading for the year ended 30 April 2024 has been in line with current market expectations and the Company expects to generate revenue of approximately £2.0 million (FY 2023: £0.8 million).
Reported Earnings • Jan 23First half 2024 earnings released: UK£0.016 loss per share (vs UK£0.026 loss in 1H 2023)First half 2024 results: UK£0.016 loss per share (improved from UK£0.026 loss in 1H 2023). Net loss: UK£2.59m (loss narrowed 37% from 1H 2023). Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 8.5% growth forecast for the Electrical industry in Germany. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has fallen by 47% per year, which means it is performing significantly worse than earnings.
お知らせ • Nov 24Ilika plc to Report First Half, 2024 Results on Jan 23, 2024Ilika plc announced that they will report first half, 2024 results on Jan 23, 2024
Reported Earnings • Aug 20Full year 2023 earnings released: UK£0.046 loss per share (vs UK£0.047 loss in FY 2022)Full year 2023 results: UK£0.046 loss per share. Net loss: UK£7.30m (loss widened 2.3% from FY 2022). Revenue is forecast to grow 49% p.a. on average during the next 3 years, compared to a 8.7% growth forecast for the Electrical industry in Germany.
お知らせ • Aug 18Ilika plc, Annual General Meeting, Sep 20, 2023Ilika plc, Annual General Meeting, Sep 20, 2023, at 13:00 Coordinated Universal Time. Location: At the offices of Eversheds Sutherlands LLP One Wood Street, London EC2V 7WS London United Kingdom
Reported Earnings • Jul 14Full year 2023 earnings released: UK£0.046 loss per share (vs UK£0.047 loss in FY 2022)Full year 2023 results: UK£0.046 loss per share. Net loss: UK£7.30m (loss widened 2.3% from FY 2022). Revenue is forecast to grow 46% p.a. on average during the next 3 years, compared to a 8.4% growth forecast for the Electrical industry in Germany.
お知らせ • May 23Ilika plc to Report Fiscal Year 2023 Results on Jul 13, 2023Ilika plc announced that they will report fiscal year 2023 results on Jul 13, 2023
お知らせ • May 22Ilika plc Provides Revenue Guidance for the Year Ended 30 April 2023Ilika plc announced that unaudited trading for the year ended 30 April 2023 has been in line with management expectations. The Company expects to announce revenues of approximately £0.8 million (2022: £0.5 million).
お知らせ • May 11Ilika plc Announces First Customer Shipments of Stereax M300 Stacked BatteriesIlika announced it has made a number of first customer shipments of stacked Stereax® M300 batteries from its UK manufacturing facility. Further to its announcement of 11 April 2023, these shipments are the first of a series of planned deliveries of Stereax M300 batteries to customers including CubeWorks, the developer of millimeter-scale smart sensing solutions for IoT, and Lura Health, a leading developer of wearable intraoral biosensors for salivary diagnostics. Stereax batteries can be configured such that they can be stacked, which provides customers with the flexibility to adapt the battery capacity for their application. The small form factor of M300 batteries is of particular interest to Ilika's customers due to their compact, high-density and high-power characteristics. CubeWorks is designing CubiSensTM, a next generation sensing platform, aiming to transform biopharma cold chain logistics, security control, asset protection and environment monitoring. Lura Health has developed the world's first salivary diagnostic, wearable sensor, first embedded in traditional orthodontic appliances including retainers, bands, and brackets, and eventually in prosthodontic appliances including dentures, implants, and bridges. Worn in the mouth continually throughout the day, it continually measures analytes in saliva, and provides real time streams of health data by Bluetooth Low Energy to a smartphone. Cirtec Update Ilika and Cirtec Medical LLC ('Cirtec'), a strategic outsourcing partner of complex medical devices including minimally invasive and active implantable devices, are continuing to finalise the terms of their intended partnership.
Board Change • Mar 24Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. Independent Non-Executive Director Monika Biddulph was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Reported Earnings • Jan 20First half 2023 earnings released: UK£0.03 loss per share (vs UK£0.022 loss in 1H 2022)First half 2023 results: UK£0.03 loss per share (further deteriorated from UK£0.022 loss in 1H 2022). Net loss: UK£4.08m (loss widened 25% from 1H 2022). Revenue is forecast to grow 63% p.a. on average during the next 3 years, compared to a 8.9% growth forecast for the Electrical industry in Germany.
お知らせ • Nov 17+ 1 more updateIlika plc Appoints Jason Stewart as Chief Financial Officer to the Board of Directors, Effective January 3, 2023Ilika plc announced the appointment of Jason Stewart as Chief Financial Officer (CFO) to the Board of Directors, effective as of 3 January 2023. Jason is a senior Finance Director and Executive with significant commercial experience in the manufacturing sector. Most recently, Jason was the Interim CFO at Sunseeker International ltd where he successfully managed the company through the COVID-19 crisis, managing costs and re-establishing production subsequent to the lockdown. A CIMA qualified accountant, Jason joined Sunseeker in 2010 and held several senior roles including Director of Commercial Finance & IT andHead of Strategy & Performance Management. Prior to this, he spent five years with B&Q ltd in various finance roles after he completed his professional training with Kerry Foods ltd. He brings with him a wealth of knowledge across financial functions, with particular expertise in project appraisals, performance management and business development. The appointment follows the departure of the previous CFO, Steve Boydell, who stepped down in July this year to pursue other opportunities. Jason Robert Fredrick Stewart, age 44, he was Director of Sunseeker USA Holdings Inc.
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. Independent Non-Executive Director Monika Biddulph was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Reported Earnings • Aug 20Full year 2022 earnings released: UK£0.047 loss per share (vs UK£0.025 loss in FY 2021)Full year 2022 results: UK£0.047 loss per share (down from UK£0.025 loss in FY 2021). Net loss: UK£7.13m (loss widened 102% from FY 2021). Over the next year, revenue is forecast to grow 102%, compared to a 17% growth forecast for the Electrical industry in Germany.
お知らせ • Aug 18Ilika plc, Annual General Meeting, Sep 20, 2022Ilika plc, Annual General Meeting, Sep 20, 2022, at 13:00 Coordinated Universal Time. Location: Eversheds Sutherlands LLP One Wood Street London United Kingdom
Reported Earnings • Jul 14Full year 2022 earnings released: UK£0.047 loss per share (vs UK£0.025 loss in FY 2021)Full year 2022 results: UK£0.047 loss per share (down from UK£0.025 loss in FY 2021). Net loss: UK£7.13m (loss widened 102% from FY 2021). Over the next year, revenue is forecast to grow 81%, compared to a 11% growth forecast for the industry in Germany.
お知らせ • May 12+ 1 more updateIlika plc to Report Fiscal Year 2022 Results on Jul 13, 2022Ilika plc announced that they will report fiscal year 2022 results on Jul 13, 2022
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 1 highly experienced director. Independent Non-Executive Director Monika Biddulph was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Recent Insider Transactions • Mar 23Finance Director recently sold €143k worth of stockOn the 21st of March, Stephen Boydell sold around 112k shares on-market at roughly €1.28 per share. This was the largest sale by an insider in the last 3 months. Stephen has been a seller over the last 12 months, reducing personal holdings by €146k.
お知らせ • Feb 26Ilika plc Announces Resignation of Steve Boydell, Chief Financial Officer, with Effect from July 2022Ilika plc announced the resignation of Steve Boydell, Chief Financial Officer, with effect from July 2022. Steve has decided to step down from his position to pursue other opportunities. To ensure an orderly transition, Steve will continue in his role until after the completion of the Company's current financial reporting period. The Company has commenced the search for a successor and a further announcement will be made in due course.
Board Change • Feb 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Independent Non-Executive Director Monika Biddulph was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Reported Earnings • Jan 22First half 2022 earnings: EPS in line with analyst expectations despite revenue beatFirst half 2022 results: UK£0.022 loss per share (down from UK£0.012 loss in 1H 2021). Net loss: UK£3.27m (loss widened 101% from 1H 2021). Revenue exceeded analyst estimates by 61%. Over the next year, revenue is forecast to grow 193%, compared to a 14% growth forecast for the industry in Germany.
Reported Earnings • Aug 20Full year 2021 earnings released: UK£0.025 loss per share (vs UK£0.03 loss in FY 2020)Full year 2021 results: Net loss: UK£3.53m (loss widened 14% from FY 2020).
Reported Earnings • Jul 08Full year 2021 earnings released: UK£0.025 loss per share (vs UK£0.03 loss in FY 2020)Full year 2021 results: Net loss: UK£3.53m (loss widened 14% from FY 2020).
お知らせ • Jun 22Ilika plc Provides Revenues Guidance for the Year Ended April 30, 2021Ilika plc provided revenues guidance for the year ended April 30, 2021. Trading for the year ended 30 April 2021 has been in line with management expectations. The company expects to announce revenues of approximately £2.3 million (2020: £2.8 million).
Is New 90 Day High Low • Jan 26New 90-day high: €3.20The company is up 233% from its price of €0.96 on 28 October 2020. The German market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electrical industry, which is up 54% over the same period.
Reported Earnings • Jan 16First half 2021 earnings released: UK£0.012 loss per shareFirst half 2021 results: Net loss: UK£1.62m (loss widened 13% from 1H 2020).
Is New 90 Day High Low • Dec 23New 90-day high: €1.25The company is up 40% from its price of €0.89 on 24 September 2020. The German market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electrical industry, which is up 18% over the same period.
Is New 90 Day High Low • Nov 12New 90-day high: €1.12The company is up 65% from its price of €0.68 on 14 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electrical industry, which is up 12% over the same period.
お知らせ • Nov 12Ilika plc to Report First Half, 2021 Results on Jan 14, 2021Ilika plc announced that they will report first half, 2021 results on Jan 14, 2021
